A global medical device company launched a study to expand their product’s use for the treatment of OCD.
Study
After a year of recruitment efforts, only 28 participants had been enrolled, far short of the necessary 100 participants.
Strategy
nRollmed worked closely with site staff to provide qualified pre-screened leads that fit the study’s specifications, including the volume of leads that a site was able to process each month, all within the sponsor’s budget
Results
2,249
leads provided by nRollmed
42%
of patients recruited by nRollmed while active
11
months of recruitment time saved
nRollmed saves medical device company almost a year on OCD trial
